Indivior Pharmaceuticals Inc (INDV) returns
Indivior Pharmaceuticals returns over 10 years
$1,000 invested in Indivior Pharmaceuticals ten years ago was worth $1,823 at the close on October 30, 2026, with dividends reinvested: an average return of 6.2% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -1.3% | — | $986.61 | -0.9% |
| 3 months | -12.1% | — | $879.41 | +2.1% |
| Year to date | -1.4% | — | $985.79 | +11.7% |
| 1 year | +21.4% | — | $1,214 | +12.4% |
| 3 years | +80.5% | +21.7% | $1,805 | +88.5% |
| 5 years | +108.7% | +15.8% | $2,087 | +76.0% |
| 10 years | +82.3% | +6.2% | $1,823 | +316.6% |
Indivior Pharmaceuticals return by calendar year
| Year | INDV | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -1.4% | +11.7% | -13.1% |
| 2025 | +188.7% | +17.7% | +170.9% |
| 2024 | -18.6% | +24.9% | -43.5% |
| 2023 | -29.8% | +26.2% | -56.0% |
| 2022 | +26.1% | -18.2% | +44.3% |
| 2021 | +135.5% | +28.7% | +106.7% |
| 2020 | +181.7% | +18.4% | +163.4% |
| 2019 | -61.5% | +31.2% | -92.7% |
| 2018 | -75.5% | -4.6% | -70.9% |
| 2017 | +54.9% | +21.7% | +33.2% |
| 2016 | +34.5% | +12.0% | +22.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: INDV financials · INDV valuation
No forecast, no recommendation. This page describes Indivior Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.